1. |
Lemaire R. Strategies for blood management in orthopaedic and trauma surgery[J]. J Bone Joint Surg Br, 2008, 90(9):1128-1136.
|
2. |
Sukeik M, Alshryda S, Haddad FS, et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement[J]. J Bone Joint Surg Br, 2011, 93(1):39-46.
|
3. |
Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty[J]. Anesth Analg, 1997, 84(4):839-844.
|
4. |
Jansen AJ, Andreica S, Claeys M, et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty[J]. Br J Anaesth, 1999, 83(4):596-601.
|
5. |
Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery[J]. Acta Chir Belg, 2007, 107(4):397-401.
|
6. |
Ido K, Neo M, Asada Y, et al. Reduction of blood loss using tranexamic acid intotal knee and hip arthroplasties[J]. Arch Orthop Trauma Surg, 2000, 120(9):518-520.
|
7. |
Niskanen RO, Korkala OL. Tranexamic acid reduces blood loss in cemented hip arthroplasty-a randomized, double-blind study of 39 patients with osteoarthritis[J]. Acta Orthop, 2005, 76(6):829-832.
|
8. |
Garneti N, Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid[J]. J Arthroplasty, 2004, 19(4):488-492.
|
9. |
Benoni G, Lethagen S, Nilsson P, et al. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty[J]. Acta Orthop Scand, 2000, 71(3):250-254.
|
10. |
Benoni G, Fredin H, Knebel R, et al. Blood conservation with tranexamic acid in total hip arthroplasty-a randomized, double-blind study in 40 primary operations[J]. Acta Orthop Scand, 2001, 72(5):442-448.
|
11. |
Ekbäck G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery[J]. Anesth Analg, 2000, 91(5):1124-1130.
|
12. |
Husted H, Blønd L, Sonne-Holm S, et al. Tranexamic acid reduces blood loss an blood transfusions in primary total hip arthroplasty:a prospective randomized double-blind study in 40 patients[J]. Acta Orthop Scand, 2003, 74(6):665-669.
|
13. |
Johansson T, Pettersson LG, Lisander B. Tranexamic acid in total hip arthroplast saves blood and money:a randomized, double-blind study in 100 patients[J]. Act Orthop, 2005, 76(3):314-319.
|
14. |
Lemay E, Guay J, Côté C, et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement[J]. Can J Anaest, 2004, 51(1):31-37.
|
15. |
Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases[J]. Int Orthop, 2004, 28(2):69-73.
|
16. |
Gill JB, Rosenstein A. The use of antifibrinolytic agents in total hip arthroplasty:meta-analysis[J]. J Arthroplasty, 2006, 21(6):869-873.
|
17. |
Andersson L, Eriksson O, Hedlund PO, et al. Special considerations with regard to dosage of tranexamic acid in patients with chronic renal diseases[J]. Urol Res, 1978, 6(2):83-88.
|
18. |
Eriksson O, Kjellman H, Pilbrant A, et al. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers[J]. Eur J Clin Pharmacol, 1974, 7(5):375-380.
|
19. |
Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids[J]. J Clin Pathol(R Coll Pathol), 1980, 14:41-47.
|
20. |
Sano K, Hakumizu H, Kojima T, et al. Absorption and excretion of tranexamic acid in human[J]. Clin Pharmacol Ther, 1976(7):375-382.
|